Search

Mark Rosenbaum

Examiner (ID: 3538, Phone: (571)272-4523 , Office: P/3725 )

Most Active Art Unit
3725
Art Unit(s)
3201, 3202, 3103, 3206, 3725, 3203, 3209, 3204, 2899, 3502, 3505
Total Applications
4526
Issued Applications
3830
Pending Applications
109
Abandoned Applications
597

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18784661 [patent_doc_number] => 20230372254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => FORTIFIED MICRONUTRIENT SALT FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/067541 [patent_app_country] => US [patent_app_date] => 2022-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12127 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18067541 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/067541
FORTIFIED MICRONUTRIENT SALT FORMULATIONS Dec 15, 2022 Abandoned
Array ( [id] => 18451922 [patent_doc_number] => 20230193201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => METHODS FOR PRODUCING IMMUNE CELL CULTURES [patent_app_type] => utility [patent_app_number] => 18/063982 [patent_app_country] => US [patent_app_date] => 2022-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10993 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063982 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/063982
METHODS FOR PRODUCING IMMUNE CELL CULTURES Dec 8, 2022 Pending
Array ( [id] => 18404439 [patent_doc_number] => 20230165789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-01 [patent_title] => IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE [patent_app_type] => utility [patent_app_number] => 18/076023 [patent_app_country] => US [patent_app_date] => 2022-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20822 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076023 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/076023
IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE Dec 5, 2022 Pending
Array ( [id] => 18389920 [patent_doc_number] => 20230158138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => MODIFIED GENE VACCINES AGAINST AVIAN CORONAVIRUSES AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/058513 [patent_app_country] => US [patent_app_date] => 2022-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13455 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18058513 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/058513
MODIFIED GENE VACCINES AGAINST AVIAN CORONAVIRUSES AND METHODS OF USING THE SAME Nov 22, 2022 Pending
Array ( [id] => 18266178 [patent_doc_number] => 20230087420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => CARBON DOTS FOR DIAGNOSTIC ANALYSIS AND DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 17/992783 [patent_app_country] => US [patent_app_date] => 2022-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10282 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992783 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/992783
CARBON DOTS FOR DIAGNOSTIC ANALYSIS AND DRUG DELIVERY Nov 21, 2022 Abandoned
Array ( [id] => 18522887 [patent_doc_number] => 20230233536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA [patent_app_type] => utility [patent_app_number] => 18/053865 [patent_app_country] => US [patent_app_date] => 2022-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13796 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18053865 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/053865
Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria Nov 8, 2022 Issued
Array ( [id] => 18583177 [patent_doc_number] => 20230265437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use [patent_app_type] => utility [patent_app_number] => 18/048577 [patent_app_country] => US [patent_app_date] => 2022-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44045 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048577 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/048577
RNAi Agents for Inhibiting Expression of Matrix Metalloproteinase 7 (MMP7), Compositions Thereof, and Methods of Use Oct 20, 2022 Pending
Array ( [id] => 18449387 [patent_doc_number] => 20230190663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/950573 [patent_app_country] => US [patent_app_date] => 2022-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950573 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/950573
PRUSSIAN BLUE NANOPARTICLES FUNCTIONALIZATION WITH LATENCY REVERSING AGENTS AND BROADLY NEUTRALIZING ANTIBODIES, AND APPLICATIONS THEREOF Sep 21, 2022 Pending
Array ( [id] => 18581656 [patent_doc_number] => 20230263910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => AAV VECTORS TARGETED TO THE CENTRAL NERVOUS SYSTEM [patent_app_type] => utility [patent_app_number] => 17/933937 [patent_app_country] => US [patent_app_date] => 2022-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34787 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17933937 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/933937
AAV VECTORS TARGETED TO THE CENTRAL NERVOUS SYSTEM Sep 20, 2022 Pending
Array ( [id] => 19195361 [patent_doc_number] => 11992580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-28 [patent_title] => Method of soft tissue augmentation [patent_app_type] => utility [patent_app_number] => 17/941713 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5379 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941713 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/941713
Method of soft tissue augmentation Sep 8, 2022 Issued
Array ( [id] => 19792365 [patent_doc_number] => 12233289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-25 [patent_title] => Methods for fixing hair and skin [patent_app_type] => utility [patent_app_number] => 17/941675 [patent_app_country] => US [patent_app_date] => 2022-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15183 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941675 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/941675
Methods for fixing hair and skin Sep 8, 2022 Issued
Array ( [id] => 18550883 [patent_doc_number] => 20230248884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => COMPOSITIONS AND METHODS FOR MODULATING WOUND HEALING AND REGENERATION [patent_app_type] => utility [patent_app_number] => 17/929886 [patent_app_country] => US [patent_app_date] => 2022-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929886 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/929886
COMPOSITIONS AND METHODS FOR MODULATING WOUND HEALING AND REGENERATION Sep 5, 2022 Abandoned
Array ( [id] => 18107994 [patent_doc_number] => 20230000874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => PEMETREXED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/898558 [patent_app_country] => US [patent_app_date] => 2022-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9330 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898558 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/898558
PEMETREXED FORMULATIONS Aug 29, 2022 Abandoned
Array ( [id] => 18091283 [patent_doc_number] => 20220409624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => PEMETREXED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/898984 [patent_app_country] => US [patent_app_date] => 2022-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9330 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898984 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/898984
PEMETREXED FORMULATIONS Aug 29, 2022 Abandoned
Array ( [id] => 18091282 [patent_doc_number] => 20220409623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => PEMETREXED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/898637 [patent_app_country] => US [patent_app_date] => 2022-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9335 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898637 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/898637
PEMETREXED FORMULATIONS Aug 29, 2022 Abandoned
Array ( [id] => 18649840 [patent_doc_number] => 20230295665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => EFFICIENT GENOME EDITING IN PRIMARY MYELOID CELLS [patent_app_type] => utility [patent_app_number] => 17/822746 [patent_app_country] => US [patent_app_date] => 2022-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32045 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822746 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/822746
EFFICIENT GENOME EDITING IN PRIMARY MYELOID CELLS Aug 25, 2022 Pending
Array ( [id] => 18253485 [patent_doc_number] => 20230080524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES COMPRISING GERMANIUM TELLURIDE NANOSHEETS COATED WITH POLYVINYLPYRROLIDONE [patent_app_type] => utility [patent_app_number] => 17/893937 [patent_app_country] => US [patent_app_date] => 2022-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10036 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17893937 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/893937
Pharmaceutical composition for treating inflammatory diseases comprising germanium telluride nanosheets coated with polyvinylpyrrolidone Aug 22, 2022 Issued
Array ( [id] => 18239523 [patent_doc_number] => 20230071834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => EXPORTED RNA REPORTERS FOR LIVE-CELL MEASUREMENT [patent_app_type] => utility [patent_app_number] => 17/820235 [patent_app_country] => US [patent_app_date] => 2022-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820235 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/820235
EXPORTED RNA REPORTERS FOR LIVE-CELL MEASUREMENT Aug 15, 2022 Pending
Array ( [id] => 18435992 [patent_doc_number] => 20230183286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA [patent_app_type] => utility [patent_app_number] => 17/820005 [patent_app_country] => US [patent_app_date] => 2022-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24287 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820005 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/820005
NOVEL 3' END CAPS, 5' END CAPS AND COMBINATIONS THEREOF FOR THERAPEUTIC RNA Aug 15, 2022 Pending
Array ( [id] => 19150211 [patent_doc_number] => 11975101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-07 [patent_title] => Compositions and methods for the treatment and prophylaxis of surgical site infections [patent_app_type] => utility [patent_app_number] => 17/819008 [patent_app_country] => US [patent_app_date] => 2022-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 19386 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819008 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/819008
Compositions and methods for the treatment and prophylaxis of surgical site infections Aug 10, 2022 Issued
Menu